Chemical Properties:
Package: Bottle, Aluminum foil bag, Cardboard drum, 25kg/Drum, or according to customer's requirement. Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture and pest infestation.Manufacturer with High Purity and Stable Quality Chemical Name: Ubenimex Synonyms: Bestatin CAS: 58970-76-6 API High Quality, Commercial Production| Item | Specifications |
| Appearance | White to Off-White Powder |
| Infrared Detection | According with CP2010 Standard |
| Identification | Reactioon with CuSO4 in NaOH Solution, Reaction with 20% Acetic Acid, Ninhydrin and NaOH Solution |
| Melting Point | ~225.0℃ (dec) |
| Specific Rotation [α]20D | -15.5° ~ -18.0° (C=1 in 1N HCL) |
| Related Substance (TCL) | One Spot |
| Purity (HPLC) | ≥99.0% |
| Related Substances | ≤1.0% |
| PH | 4.5~7.0 |
| Loss on Drying | ≤0.50% |
| Residue on Ignition | ≤0.10% |
| Heavy Metals | ≤20ppm |
| Assay | ≥99.0% (T) |
| Test Standard | Chinese Pharmacopoeia (CP) |
| Usage | Active Pharmaceutical Ingredient (API) |
Description:
Specifications:
Package & Storage:
| Chemical Name | Ubenimex |
| Synonyms | Bestatin; N-[(2S,3R)-3-Amino-2-hydroxy-4-phenylbutyryl]-L-leucine |
| CAS Number | 58970-76-6 |
| CAT Number | RF-API31 |
| Stock Status | In Stock, Production Scale Up to Hundreds of Kilograms |
| Molecular Formula | C16H24N2O4 |
| Molecular Weight | 308.37 |
| Brand | Ruifu Chemical |
Advantages:
FAQ:
Application:
Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of Ubenimex (CAS: 58970-76-6) with high quality. Ubenimex (Bestatin) is a potent aminopeptidase inhibitor. Ubenimex (CAS: 58970-76-6), also known as Bestatin, a dipeptide N-[(2S,3R)-3-Amino-2-hydroxy-4-phenylbutyryl]-L-leucine is a competitive for leucine aminopeptidase and aminopeptidase-B protease inhibitor. It exerts a direct stimulating effect on lymphocytes (and monocytes) via its fixation on cell surface leucine-aminopeptidase, and an indirect effect on monocytes (and lymphocytes) via aminopeptidase B inhibition of tuftsin catabolism. Ubenimex has also been studied for use in the treatment of acute myelocytic leukemia. Ubenimex has multiple physiological functions including the ability to act as an immunomodifier and enhance the proliferation of human bone marrow granulocyte-macrophage progenitor cells to form CFU-GM colonies. Ubenimex has been used in multiple leukemia studies. Ubenimex is an immunostimulant useful in the treatment of non-lymphocytic leukemia.
